Journey Medical Corp
Journey Medical Corporation (Nasdaq Capital Market: JRNY) is a commercial-stage pharmaceutical company focused on acquiring, developing, and commercializing FDA-approved prescription pharmaceutical products for dermatological conditions. The company operates through its website at www.jmcderm.com and maintains a… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Journey Medical Corp does
In the company’s own words
Journey Medical Corporation (Nasdaq Capital Market: JRNY) is a commercial-stage pharmaceutical company focused on acquiring, developing, and commercializing FDA-approved prescription pharmaceutical products for dermatological conditions. The company operates through its website at www.jmcderm.com and maintains a specialized distribution network of over 600 specialty pharmacies and wholesalers.
The company's current product portfolio comprises eight FDA-approved prescription drugs for dermatological conditions marketed in the United States. Its major actively marketed products include Emrosi, a minocycline hydrochloride extended-release capsule approved in November 2024 for treating inflammatory lesions of rosacea in adults; Qbrexza, a topical anticholinergic cloth for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical minocycline foam for moderate-to-severe acne; and Zilxi, a topical minocycline foam for rosacea. The company also maintains a portfolio of legacy products including Exelderm for fungal skin infections, Targadox for severe acne, and Luxamend for wound healing.
Journey Medical operates with 58 full-time employees as of March 2026, with 39 in sales and marketing roles and 19 in general and administrative positions. The company employs a field sales force strategically optimized to cover over 80 percent of dermatologists in the top 50 U.S. metropolitan statistical areas and over 70 percent of the overall dermatology prescribing market.
The company's business model centers on identifying and acquiring rights to differentiated dermatology products through licensing agreements, asset purchases, and collaborations with third parties. Journey Medical generates revenue primarily from U.S. product sales, though it has begun supplying products internationally through sublicense agreements, including supplying Amzeeq to a partner in the People's Republic of China.
Journey Medical is a controlled subsidiary of Fortress Biotech, Inc., which holds a voting majority of the company's common stock through its ownership of all Class A Common Stock. The company joined the Russell 2000 Index and Russell 3000 Index in June 2025 following the annual reconstitution.
Company details
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Headquarters
- SCOTTSDALE, AZ
- Fiscal year end
- December
- CIK
- 1867066
- SIC
- 2834
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Journey Medical Corp — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Journey Medical Corp’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Journey Medical Corp and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Journey Medical Corp's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Journey Medical Corp's last four quarterly filings that the numbers alone won't show?”